Latest Shareholder Voting News

US1 Critical Minerals has provided clarity on the issuance of 50 million fee options to consultants related to its December 2025 placement, reaffirming shareholder approval is pending and no funds will be raised from this issuance.

Dundas Minerals has raised $2.5 million through a strongly supported share placement to fund gold exploration drilling at its Kalgoorlie and expanded Romano projects in Western Australia.

OncoSil Medical’s CEO Nigel Lange has agreed to a 10% salary reduction, opting instead to receive shares at a significant premium, reinforcing executive commitment to shareholder value and cost discipline.

Cannindah Resources has successfully raised over $11 million through the first tranche of its share placement, with the second tranche awaiting shareholder approval in March 2026.

DGR Global has confirmed its support for Jiangxi Copper’s acquisition offer for SolGold, endorsing the 28 pence per share bid ahead of the upcoming shareholder vote.

DGR Global has been flagged by ASX for breaching Listing Rule 10.1 after advancing $500,000 without prior shareholder approval. The company is now preparing to seek retroactive approval and address further funding tranches.

DGR Global, a major SolGold shareholder, has announced its current intention to back Jiangxi Copper's 28p per share offer, pending no better bids emerge. The SolGold board unanimously supports the scheme, with a shareholder vote set for 23 February 2026.

AuKing Mining Ltd has kicked off a $2 million share placement with a first tranche completed and seeks shareholder approval for the second. The company also plans a fresh marketing partnership with Singapore’s Bullseye Analytics, issuing options as part of the deal.

Apiam Animal Health shareholders have overwhelmingly approved the proposed acquisition by Adamantem Capital-controlled entities, clearing a critical hurdle for the $500 million deal.

Apiam Animal Health shareholders convened on 3 February 2026 to vote on a scheme of arrangement proposing acquisition by Adamantem Capital Fund II, with the board unanimously recommending approval. The scheme offers $0.87 cash per share or scrip alternatives, pending final court approval.

Little Green Pharma Ltd is set to acquire Cannatrek Ltd in a transformative merger that will create one of the largest vertically integrated medicinal cannabis companies globally, with pro-forma FY25 revenue exceeding AUD 112 million.

Aurora Energy Metals updates investors on its strategic option agreement with Eagle Energy Metals, which is set to become the first US-listed uranium explorer with SMR technology following a pending SPAC merger.